[1]
“Reclassification and analysis of clinical significance of atypical glandular cells on ThinPrep using Bethesda 2001: Geneva experience”, Swiss Med Wkly, vol. 137, no. 4546, pp. 635–635, Nov. 2007, doi: 10.4414/smw.2007.11928.